Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease

BackgroundTicagrelor is a P2Y12 receptor inhibitor used in acute coronary syndromes to reduce platelet activity and to decrease thrombus formation. Ticagrelor is associated with a reduction in mortality incremental to that observed with clopidogrel, potentially related to its non–antiplatelet effect...

Full description

Bibliographic Details
Main Authors: Matthieu Pelletier‐Galarneau, Chad R. R. N. Hunter, Kathryn J. Ascah, Rob S. B. Beanlands, Girish Dwivedi, Robert A. deKemp, Benjamin J. W. Chow, Terrence D. Ruddy
Format: Article
Language:English
Published: Wiley 2017-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
adenosine
clopidogrel
myocardial blood flow
positron emission tomography
ticagrelor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.005894

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.005894

Similar Items